New DOJ Guidance Addresses Drug prescriptions, Price-Gouging, and Antitrust Concerns in the Wake of COVID-19
The U.S. Department of Justice (DOJ) has issued a series of memoranda that discloses the department’s enforcement priorities and provides public guidance related to the ongoing coronavirus crisis. This article explores three key areas of DOJ’s policy: (1) programs that target the improper prescribing or dispensing of drugs that may be effective in treating COVID-19; (2) an initiative to prevent hoarding and price gouging of critical supplies; and (3) antitrust procedures and guidance for collaboration between companies in responding to the crisis. Click here to read more.
Click here for more Dinsmore news.
“People respond well to those that are sure of what they want.” —Anna Wintour, Editor-in-Chief…
How Energy Sources Have Changed Throughout U.S. History US Energy Information Administration7 Comments Sign up…
This Michigan Coal Plant is Being Turned Into a Giant Battery Trenton Channel Power Plant,…
Toolbox Talk: Setting The Example!! Setting a good example is not a "put-on". It's simply…
“I cannot give you the formula for success, but I can give you the formula…
Here's How Many Solar Panels You'll Need to Charge Your EV Story by Eric Mack…
This website uses cookies.